VALIDOGEN launches next-generation synthetic methanol-free promoters for Pichia pastoris protein production
VALIDOGEN GmbH, an Austrian contract research and development organisation specialising in recombinant protein expression, has announced the launch of a synthetic methanol-free promoter library for Pichia pastoris expression systems. The technology is integrated into the company’s proprietary UNLOCK PICHIA® platform and targets improved productivity and simplified bioprocess control.
A synthetic architecture designed for tunable expression
The new promoters are built on a synthetic architecture that combines engineered promoter fragments with selected sequence elements derived from native yeast promoters. This design enables tunable, time-controlled initiation of recombinant protein production without the use of external inducers. Glycerol or glucose serves as the sole carbon source throughout the production process, eliminating the metabolic burden associated with carbon source switching and reducing cellular stress during expression.
By avoiding methanol, operators also sidestep the logistical and safety requirements associated with handling this solvent at manufacturing scale – an increasingly important consideration as biologics production moves to larger facilities.
Performance data and process benefits
Using non-optimised, generic bioreactor protocols, the platform has achieved supernatant titres exceeding 20 g/L across several protein classes. Roland Weis, Head of Operations at VALIDOGEN, noted the broader significance of this result: “Controlled methanol-free expression in Pichia is not new to VALIDOGEN. We introduced and established this technology in an industrial setting more than 15 years ago, and it has been commercially implemented in bioreactors of up to 200,000 L. What is new is the level of control and productivity that can now be achieved.”
The process benefits cited by the company include enhanced productivity, lower oxygen demand, and reduced cooling requirements – all factors that bear directly on cost of goods and operational complexity at scale.
Expanding the UNLOCK PICHIA portfolio
The new promoter library is positioned as a complement to, rather than a replacement for, established methanol-induced AOX1 expression systems, which remain available through VALIDOGEN where appropriate. Thomas Purkarthofer, CEO of VALIDOGEN, explained the rationale: “Rather than replacing the well-established methanol-induced AOX1 systems, this new promoter library broadens the range of solutions we can offer our customers through the UNLOCK PICHIA platform. Enhanced productivity, simplified process control, lower oxygen demand, and reduced cooling requirements make our methanol-free Pichia protein production processes highly attractive to our customers.”
VALIDOGEN supports clients across the full development continuum, from early feasibility and lead identification through strain development, process optimisation, scale-up, and technology transfer towards commercial manufacturing.
For more information, visit: https://shorturl.at/C55xA
Digital issue: Please click here for more information
